Literature DB >> 10463458

A rating scale for psychotic symptoms (RSPS) part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations).

G Chouinard1, R Miller.   

Abstract

The authors present a new rating scale for the psychotic symptoms of schizophrenia and related psychoses. The scale links specific symptoms of psychopathology to dysfunction and overactivity of dopaminergic mechanisms underlying the processes of reward and selective attention. The Rating Scale for Psychotic Symptoms (RSPS) is a 44-item rating instrument with a seven-point severity scale for each item. Psychotic symptoms are classified into three groups: Pathological amplification of mental images (perception symptoms) (subscale 1), Distraction symptoms (including catatonia and passivity experiences) (subscale 2), and Delusions (subscale 3). A dimensional, rather than a categorical, conceptualization of psychosis is assumed. Rating is accomplished through a manual and a semi-structured interview (SSCI-RSPS). In this first of two papers, general issues about the construction of the scale and the derivation of symptom groups are discussed. Dopamine-mediated modification of cortico-striatal synapses is seen as being of critical importance in all three groups of symptoms. In this first paper, we present subscale I (perception symptoms), which includes both amplified perceptual images (illusions) and hallucinations. A total of seven illusions and 11 hallucinations are rated as individual items.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463458     DOI: 10.1016/s0920-9964(99)00012-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

Review 1.  How antipsychotics work-from receptors to reality.

Authors:  Shitij Kapur; Ofer Agid; Romina Mizrahi; Ming Li
Journal:  NeuroRx       Date:  2006-01

2.  Visual hallucinations associated with multimodal hallucinations, suicide attempts and morbidity of illness in psychotic disorders.

Authors:  Virginie-Anne Chouinard; Ann K Shinn; Linda Valeri; Philippe A Chouinard; Margaret E Gardner; A Esin Asan; Bruce M Cohen; Dost Öngür
Journal:  Schizophr Res       Date:  2019-03-03       Impact factor: 4.939

Review 3.  Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action.

Authors:  Eric A Maltbie; Gopinath S Kaundinya; Leonard L Howell
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

4.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

5.  Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.

Authors:  Orwa Dandash; Ben J Harrison; Ram Adapa; Raphael Gaillard; Francesco Giorlando; Stephen J Wood; Paul C Fletcher; Alex Fornito
Journal:  Neuropsychopharmacology       Date:  2014-08-21       Impact factor: 7.853

6.  Cognition-emotion dysinteraction in schizophrenia.

Authors:  Alan Anticevic; Philip R Corlett
Journal:  Front Psychol       Date:  2012-10-12

7.  Exploring the impact of ketamine on the experience of illusory body ownership.

Authors:  Hannah L Morgan; Danielle C Turner; Philip R Corlett; Anthony R Absalom; Ram Adapa; Fernando S Arana; Jennifer Pigott; Jenny Gardner; Jessica Everitt; Patrick Haggard; Paul C Fletcher
Journal:  Biol Psychiatry       Date:  2010-10-13       Impact factor: 13.382

8.  Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade.

Authors:  F Vinckier; R Gaillard; S Palminteri; L Rigoux; A Salvador; A Fornito; R Adapa; M O Krebs; M Pessiglione; P C Fletcher
Journal:  Mol Psychiatry       Date:  2015-06-09       Impact factor: 15.992

Review 9.  A review of abnormalities in the perception of visual illusions in schizophrenia.

Authors:  Daniel J King; Joanne Hodgekins; Philippe A Chouinard; Virginie-Anne Chouinard; Irene Sperandio
Journal:  Psychon Bull Rev       Date:  2017-06

10.  Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.

Authors:  Dorit Ben-Shachar; Rachel Karry
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.